Las Vegas, NV -- (SBWIRE) -- 10/18/2013 -- Beststocksondemand.com, is a financial newsletter and blog focused on shedding light on under-discovered small cap companies. Our team of professionals from various backgrounds work diligently to bring our members the best penny stock picks, stock market commentary, and news on all types of OTCBB and Pink Sheet companies, Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV), Affymax, Inc. (OTCMKTS:AFFY), Cereplast Inc (OTCMKTS:CERP), Jammin Java Corp (OTCMKTS:JAMN)
Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV) gained volume of 129,657 shares and the average volume of the stock remained 449,487 shares. The 52 week range of the stock remained $0.94 - $6.20 and the day range was $1.42 - $1.48.The stock opened the session at $1.48, and closed the session at $1.45. The stock showed a negative performance of -2.68% in previous trading session. InVivo Therapeutics Holdings Corp., formerly Design Source, Inc. is a development-stage company. The Company is developing and commercializing technologies for the treatment of spinal cord injuries. The Company develops biopolymer scaffolding devices for the treatment of spinal cord injuries. The biopolymer devices are designed to protect the damaged spinal cord from further secondary injury and promote neuroplasticity, a process where functional recovery can occur through the rerouting of signalling pathways to the spared healthy tissue.
Why Should Investors Buy NVIV After the Recent Fall? Just Go Here and Find Out
In previous session, Affymax, Inc. (OTCMKTS:AFFY) traded 166,028 shares and the average volume of the stock remained 443,871 shares. The 52 week range of the stock remained $0.78 - $27.74. The stock closing price stayed at $1.19. The market capitalization of the stock remained 44.61 million. The half-yearly trend of the stock remained positive 28.32 %. Affymax, Inc. is a biopharmaceutical company engaged in developing drugs to improve the treatment of serious and often life-threatening conditions. Its product candidate, peginesatide, is for the treatment of anemia in chronic kidney disease patients on dialysis. Peginesatide is a synthetic peptide-based erythropoiesis stimulating agent (ESA), designed to stimulate production of red blood cells.
For How Long AFFY Gloss will Attract Investors? Find out via this report
Cereplast Inc (OTCMKTS:CERP) volume of the stock was 12.79 million shares in the most recent session and the average volume remained 11.36 million shares. The stock plunged -0.69% and finished the prior session at the closing price of $0.0144.Cereplast, Inc. (Cereplast) is engaged in developing and commercializing bio-based resins through two product families: Cereplast Compostables Resins, which are compostable, renewable, ecologically sound substitutes for petroleum-based plastics, and Cereplast Sustainables resins (including the Cereplast Hybrid Resins product line), which replaces up to 90% of the petroleum-based content of traditional plastics with materials from renewable resources.
Will CERP Get Buyers Even After The Recent Rally? Find Out Here
Jammin Java Corp (OTCMKTS:JAMN) traded with volume of 581,250 shares and the average volume of the stock remained 371,057 shares. The stock grew 6.10 % and finished the trading at $0.435. The market capitalization of the stock remained 41.93 million. The beta of the stock remained 7.42. Jammin Java Corp. is primarily engaged in the business of providing roasted coffee on a wholesale level to the service, hospitality, office coffee service and big box store market. As of January 1, 2012, the Company planned to provide organically grown coffee, as well as fair trade or equal exchange coffee. The Company is party to a Trademark License Agreement with Marley Coffee, LLC (MCL). With respect to the License Agreement, Fifty Six Hope Road Music Limited, a Bahamas international business company (Fifty Six Hope Road), owns and controls the intellectual property rights in and to the late reggae performer, Robert Nesta Marley p/k/a Bob Marley, including Marley Coffee (the Trademark).
Will JAMN Continue To Move Higher? Find Out Here
About:Best Stock on Demand
Beststocksondemand.com is an exciting online financial terminal where stock readers, traders and investors as well as market analysts can come to discover new opportunities, ideas, situations and news. Beststocksondemand.com goal is finding the most Undervalued or should we say Value Stocks or the Next Emerging Growth Stock that might be unnoticed by Wallstreet. Beststocksondemand.com is constantly searching for exceptional investment situations that can profit both investors and traders in order to grow their gains on a well balanced portfolio.
Beststocksondemand.com is also a well-respected marketing and research firm that mainly focuses on Best Stocks on Demand, Micro-Cap Stocks and Small Cap Stocks. Beststocksondemand.com uses its strategic corporate communication services to increase investor awareness of your company. We can support developing, emerging growth and deep-rooted companies in their marketing therefore creating a more dominant and operative investor alertness.
The assembled information disseminated by Beststocksondemand.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Beststocksondemand.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.
Please read Our Full Disclaimer at: http://www.beststocksondemand.com/disclaimer.html
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)